{"version":"1.0","provider_name":"cometis AG","provider_url":"https:\/\/www.cometis.de\/de\/","title":"25. M\u00e4rz 2020 | Dermapharm setzt 2019 profitables Wachstum fort","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"tLo1v5z1Rq\"><a href=\"https:\/\/www.cometis.de\/de\/25-maerz-2020-dermapharm-setzt-2019-profitables-wachstum-fort\/\">25. M\u00e4rz 2020 | Dermapharm setzt 2019 profitables Wachstum fort<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.cometis.de\/de\/25-maerz-2020-dermapharm-setzt-2019-profitables-wachstum-fort\/embed\/#?secret=tLo1v5z1Rq\" width=\"600\" height=\"338\" title=\"&#8222;25. M\u00e4rz 2020 | Dermapharm setzt 2019 profitables Wachstum fort&#8220; &#8211; cometis AG\" data-secret=\"tLo1v5z1Rq\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.cometis.de\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/www.cometis.de\/wp-content\/uploads\/2024\/12-old\/Cometis-Mobile-Logo-1.png","thumbnail_width":171,"thumbnail_height":31,"description":"Corporate news to the archive Dermapharm setzt 2019 profitables Wachstum fort \u00bb\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Konzernumsatz 2019 um rund 23% gegen\u00fcber Vorjahr auf 701 Mio. EUR gestiegen \u00bb\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Bereinigtes EBITDA um rund 24% gegen\u00fcber Vorjahr erh\u00f6ht auf 178 Mio. EUR \u00bb\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Bereinigte EBITDA-Marge weiter verbessert auf 25,3% \u00bb\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Wichtige Weichen f\u00fcr profitables Wachstum in 2020 gestellt Gr\u00fcnwald, 25. [&hellip;]"}